Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | TSHR | P16473 | 2/20 | 0.71 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | VCP | P55072 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.44 |
| ▸ | HBB | P68871 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | PNP | P00491 | 1/20 | 0.40 |
| ▸ | EDNRA | P25101 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9022143 | 0.91 | KMT2A (0.62) | MEN1KMT2ATSHRPDE3ABLM | |
| SCHEMBL14421495 | 0.91 | MEN1 (0.70) | MEN1KMT2ATSHRPDE3ABLM | |
| SCHEMBL10364407 | 0.90 | MEN1 (0.61) | MEN1KMT2ATSHRPDE3ABLM | |
| SCHEMBL2576527 | 0.89 | MEN1 (0.66) | MEN1KMT2ATSHRPDE3ABLM | |
| SCHEMBL14963622 | 0.89 | KMT2A (0.66) | MEN1KMT2ATSHRPDE3ABLM | |
| SCHEMBL10481450 | 0.88 | MEN1 (0.72) | MEN1KMT2ATSHRPDE3ABLM | |
| SCHEMBL14421454 | 0.86 | MEN1 (0.69) | MEN1KMT2ATSHRPDE3ABLM | |
| SCHEMBL14963621 | 0.86 | MEN1 (0.63) | MEN1KMT2ATSHRPDE3ABLM | |
| SCHEMBL8446145 | 0.84 | MEN1 (0.67) | MEN1KMT2ATSHRPDE3ABLM | |
| SCHEMBL9583727 | 0.84 | BLM (0.72) | MEN1KMT2ATSHRPDE3ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1565470-A2 | PROCESS FOR THE PREPARATION OF GANCICLOVIR | Ranbaxy Laboratories Limited (IN) | 2005-08-24 | — | — | EP | claimed |
| WO-2004039808-A2 | PROCESS FOR THE PREPARATION OF GANCICLOVIR | RANBAXY LABORATORIES LIMITED (US) | 2004-05-13 | — | — | WO | claimed |
| CN-115724845-B | Triacetyl ganciclovir preparation method of pyrrosir | 湖北省宏源药业科技股份有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-113929580-B | Method for recovering side chains in ganciclovir condensate mother liquor | 湖北省宏源药业科技股份有限公司 | 2024-10-18 | — | — | CN | disclosed |
| CN-114478531-B | Method for recycling ganciclovir condensate synthetic mother liquor | 湖北省宏源药业科技股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-113149988-B | Preparation method and application of ganciclovir | 海南锦瑞制药有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-112608313-B | Treatment method of mother liquor precipitate in production of triacetyl ganciclovir | 河北合佳医药科技集团股份有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-115724845-A | Preparation method of high-purity triacetylganciclovir | 湖北省宏源药业科技股份有限公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-114478531-A | Method for recycling ganciclovir condensation compound synthesis mother liquor | 湖北省宏源药业科技股份有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-113149988-A | Ganciclovir preparation method and application | 海南锦瑞制药有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-108467396-B | Ganciclovir preparation method | 安徽海康药业有限责任公司 | 2021-07-20 | — | — | CN | disclosed |
| WO-2003033498-A2 | A PROCESS FOR THE TREATMENT OF GANCICLOVIR INTERMEDIATE N2-ACETYL-9-(1, 3-DIACETOXY-2-PROPOXYMETHYL) GUANINE | RANBAXY LABORATORIES LIMITED (IN) | 2003-04-24 | — | — | WO | disclosed |
| EP-0532878-B1 | Process for producing acyclic nucleosides | AJINOMOTO KK (JP) | 1999-06-30 | — | — | EP | disclosed |
| US-5648489-A | PREPARING 9-((1,3-DIHYDROXY-2-PROPOXY)METHYL)GUANINE FROM A PROTECTED GUANINE AND 2-ACETOXYMETHOXY-1,3-DIACETOXYPROPANE | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) | 1997-07-15 | — | — | US | disclosed |
| US-5583225-A | REACTING N2, N9-DIPROTECTED GUANINE WITH DIACETOXYPROPANE IN THE PRESENCE OF A MIXTURE OF AN ACID AND ACETIC ANHYDRIDE | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1996-12-10 | — | — | US | disclosed |
| EP-0532878-A2 | Process for producing acyclic nucleosides | Ajinomoto Co., Inc. (JP) | 1993-03-24 | — | — | EP | disclosed |
| US-4816447-A | HERPES VIRUS | MERCK & CO., INC. (US) | 1989-03-28 | — | — | US | disclosed |
| EP-0074306-B1 | ANTI-VIRAL GUANINE DERIVATIVES | MERCK & CO. INC. (US) | 1988-06-01 | — | — | EP | disclosed |
| EP-0165164-A1 | Anti-viral compounds, their preparation and anti-viral compositions | MERCK & CO. INC. (US) | 1985-12-18 | — | — | EP | disclosed |
| EP-0074306-A2 | Anti-viral guanine derivatives | MERCK & CO. INC. (US) | 1983-03-16 | — | — | EP | disclosed |